Fresenius | FRE - Interest Expense On Debt


Fresenius reported EUR81M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akzo Nobel EUR 68M 26M Jun/2025
Alcon AG USD 53M 1000K Jun/2026
AstraZeneca USD 371M 31M Sep/2026
BASF EUR 229M 7M Sep/2026
Bayer EUR 675M 87M Dec/2025
Beiersdorf EUR 14M 6.5M Jun/2026
DaVita Healthcare Partners USD 17.82B 107.02M Sep/2026
Demant DKK 424M 26M Jun/2026
E.ON EUR 729M 174M Sep/2026
Essilor EUR 188M 20M Jun/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 97.5M 14.5M Sep/2026
Getinge SEK 133M 31M Jun/2026
Givaudan CHF 58M 7M Dec/2025
GlaxoSmithKline GBP 219M 98M Sep/2026
GN Store Nord DKK 154M 132M Sep/2026
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 119M 18M Sep/2026
Novartis USD 468M 6M Sep/2026
Philips EUR 84M 1000K Sep/2026
Roche Holding CHF 304M 7.5M Jun/2025
RWE EUR 138M 214M Dec/2025
Sanofi EUR 222M 65M Sep/2026
Smith & Nephew USD 69M 1000K Dec/2025